Cargando…
APOBEC3B, a molecular driver of mutagenesis in human cancers
Human cancers results in large part from the accumulation of multiple mutations. The progression of premalignant cells is an evolutionary process in which mutations provide the fundamental driving force for genetic diversity. The increased mutation rate in premalignant cells allows selection for inc...
Autores principales: | Zou, Jun, Wang, Chen, Ma, Xiangyi, Wang, Edward, Peng, Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450379/ https://www.ncbi.nlm.nih.gov/pubmed/28572915 http://dx.doi.org/10.1186/s13578-017-0156-4 |
Ejemplares similares
-
Mechanisms of APOBEC3 mutagenesis in human cancer cells
por: Petljak, Mia, et al.
Publicado: (2022) -
An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers
por: Chan, Kin, et al.
Publicado: (2015) -
Molecular mechanism and clinical impact of APOBEC3B-catalyzed mutagenesis in breast cancer
por: Harris, Reuben S
Publicado: (2015) -
Genetic inhibitors of APOBEC3B-induced mutagenesis
por: Mertz, Tony M., et al.
Publicado: (2023) -
Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B
por: Shi, K., et al.
Publicado: (2016)